fbpx

Thursday 3rd October

Ensuring better outcomes in LVAD therapy: Recommendations, clinical evidence and real-life examples

Options in the treatment of MR: A new horizon of therapy with transcatheter mitral valve implantation (TMVI)

Surgical AF ablation: Treatment is the new gold standard

 

Click here for the full programme.

Reserve your seat by emailing AFConnect@AtriCure.com

Restoring pericardial anatomy improves patient outcomes after cardiac surgery

Mitral valve: Repair or replace, with respect

Moderator: Dr Patrick Perier, Klinik für Kardiochirurgie, Campus Bad Neustadt, Germany

Mitral valve replacement: When and why?
Dr Guillermo Reyes, La Princesa Hospital, Madrid, Spain

Tips and tricks for endoscopic mitral surgery
Mr Joseph Zacharias, Blackpool Victoria Hospital, UK

A new chordal replacement platform for minimally invasive mitral repair
Dr Stefano Benussi, Spedali Civili di Brescia, Italy

Register to Attend Today:  www.cryolife.com/EACTS

Update on CytoSorb blood purification therapy: Clinical and economical effects in cardiac surgery

Chairs: Jan Gummert, Bad Oeynhausen, Germany & Günther Laufer, Vienna, Austria

Intraoperative use in endocarditis -The REMOVE trial
Torsten Doenst, Jena, Germany

Improved clinical outcome in ECMO patients
Federico Pappalardo, Milan, Italy

Enhanced hemodynamic and metabolic stability in aortic surgery
Maximilian Pichlmaier, Munich, Germany

Removal of Ticagrelor during emergency heart surgery and reduction of complications and costs
Stephan Geidel, Hamburg, Germany

For any questions, please contact Stefan Baudis – stefan.baudis@cytosorbents.com

Modern treatment of aortic valve stenosis – critical SAVR and TAVI valve performance factors

The role of aprotinin in current practice: 3-year real-life data from EU centres

Friday 4th October

Treatment of mitral regurgitation across the patient spectrum.
The future is now.

 

Please see HERE for the programme

Aortic valve repair to replacement: From pediatric to adult

Half century of LAA occlusion: Where are we?

 

Click here for the full programme.

Reserve your seat by emailing AFConnect@AtriCure.com

New perspectives with regards to bleeding in cardiac surgery. HEMOBLAST Bellows™ and SPOT GRADE™

Future of aortic arch treatment

Prof. N. Doll, Sana Stuttgart; Prof. H. Jakob, Essen

Feasibility study for next generation of branched FET-prothesis
Prof. Grabenwöger, Vienna

Frozen elephant trunk: The debranch first technique
Prof. Castiglioni., San Raffaele

Treating aortic arch with branched stent-graft. Another step forward for cardiac surgery
Prof. Augusto D´Onofrio, Padova

Mid-term experience with the NEXUS™ aortic arch branched stent-graft
Prof. Lachat, Zurich

Register to Attend Today:  www.cryolife.com/EACTS

CytoSorb therapy in various cardiac surgery indications

Chairs: Christian Hagl, Munich, Germany & Carlos Mestres, Zurich, Switzerland

The emergency surgical patient under Ticagrelor
Pascale Leprince, Paris, France

Effects on outcome in mitral valve infective endocarditis
Daniel Wendt, Essen, Germany

Faster control of refractory vasoplegic shock
Nandor Marczin, Harefield, UK

Reduction of inflammation in heart transplantation
Endre Németh, Budapest, Hungary

For any questions, please contact Stefan Baudis – stefan.baudis@cytosorbents.com

Shifting into the new paradigm for the aortic valve replacement

 

Click here for the full programme.

Future of cardiac surgery through minimally invasive surgery – Why wait?

Combining knowledge and experience to set new standards in LVAD therapy

The treatment of mitral regurgitation in 2019 and beyond

Novel technologies from Meril’s Armamentarium

Current and future strategies for the treatment of aortic arch disease

Chair:
J Bavaria, Philadelphia

Presenters:
M Shrestha, Hannover – Acute Type A Dissection
M Czerny, Freiburg – Chronic Dissection
W Szeto, Philadelphia– Aneurysm

Panel member:
R Gottardi, Austria

 

For any questions, please contact Paula Goudie – p.goudie@terumoaortic.com

Saturday 5th October